Development of a targeted polymorph screening approach for a complex polymorphic and highly solvating API.

Elucidation of the most stable form of an active pharmaceutical ingredient (API) is a critical step in the development process. Polymorph screening for an API with a complex polymorphic profile can present a significant challenge. The presented case illustrates an extensively polymorphic compound with an additional propensity for forming stable solvates. In all, 5 anhydrous forms and 66 solvated forms have been discovered. After early polymorph screening using common techniques yielded mostly solvates and failed to uncover several key anhydrous forms, it became necessary to devise new approaches based on an advanced understanding of crystal structure and conformational relationships between forms. With the aid of this analysis, two screening approaches were devised which targeted high-temperature desolvation as a means to increase conformational populations and enhance overall probability of anhydrous form production. Application of these targeted approaches, comprising over 100 experiments, produced only the known anhydrous forms, without appearance of any new forms. The development of these screens was a critical and alternative approach to circumvent solvation issues associated with more conventional screening methods. The results provided confidence that the current development form was the most stable polymorph, with a low likelihood for the existence of a more-stable anhydrous form.

A practical algorithm to remove cosmic spikes in Raman imaging data for pharmaceutical applications.

Raman dispersive microscopic imaging techniques are finding ever-increasing applications in pharmaceutical research for their ability to provide spatial and spectral information about the sample. Spectral data acquired from dispersive Raman instruments utilizing charge-coupled device detectors are characterized by occasional high intensity spikes arising from cosmic ray events. These random cosmic spikes are superimposed on chemically meaningful spectra. Due to their high intensity and potential influence on variance structures, it is often crucial to filter cosmic spikes from data prior to the use of multivariate algorithms to extract chemical information from the image cube. Some extremely challenging cosmic spikes are found to seriously interfere with multivariate data analysis for our application, e.g., spikes with bandwidth greater than the bandwidth from species of interest, spikes in neighboring image pixels occurring at the same spectral channels, spikes right on top of the band of interest, etc. A practical algorithm is proposed for semiautomated cosmic spike removal. The algorithm is computationally efficient, conceptually simple, and easy to implement. It is an alternative to methods using repetitive measurements by taking advantage of the spatial characteristic of imaging techniques and existing knowledge from the formulation. The algorithm has been shown to generate recovered spectra with negligible spectral distortion. The utility of the algorithm will be illustrated by the analysis of Raman images of pharmaceutical samples.

Drug characterization in low dosage pharmaceutical tablets using Raman microscopic mapping.

Raman micro-spectroscopic mapping is utilized to analyze pharmaceutical tablets containing a low concentration (0.5% w/w) of active pharmaceutical ingredient (API). The domain sizes and spatial distributions of the API and the major excipients are obtained. Domain size of the API is found to be dependent upon the particle size distribution of the ingoing API material, making the Raman maps good indicators of the source of API used in tablet manufacturing. Multivariate classification was performed to simultaneously check for the presence of two undesired API polymorphs within tablets. Raman mapping was demonstrated capable of detecting in the tablet matrix as little as 10% form conversion of the low-dosage (0.5% w/w) API, which is equivalent to detection of a 0.05% w/w polymorphic impurity. Overall, the information provided by Raman micro-spectroscopic mapping was found to have potential utility for manufacturing process optimization or predictive stability assessments.

Solvent effects on the conversion of dicopper(II) micro-eta(2):eta(2)-peroxo to bis-micro-oxo dicopper(III) complexes: direct probing of the solvent interaction.

A new tridentate ligand, PYAN, is employed to investigate solvent influences for dioxygen reactivity with [Cu(PYAN)(MeCN)]B(C(6)F(5))(4) (1). Stopped-flow kinetic studies confirm that the adducts [[u(II)(PYAN)]2)(O(2))][B(C(6)F(5))(4)](2) (2(Peroxo)) and [[u(III)(PYAN)]2)(O)(2)][B(C(6)F(5))(4)](2) (2(Oxo)) are in rapid equilibrium. Thermodynamic parameters for the equilibrium between 2(Peroxo) and 2(Oxo) re as follows: THF, deltaH degrees approximately -15.7 kJ/mol, deltaS degrees approximately -83 J/K.mol; acetone, deltaH degrees approximately -15.8 kJ/mol, deltaS degrees approximately -76 J/K.mol. UV-visible absorption and resonance Raman spectroscopic signatures demonstrate that the equilibrium is highly solvent dependent; the mixture is mostly 2(Peroxo) in CH(2)Cl(2), but there are significantly increasing quantities of 2(Oxo) along the series methylene chloride --> diethyl ether --> acetone --> tetrahydrofuran (THF). Copper(II)-N(eq) stretches (239, 243, 244, and 246 cm(-)(1) in CH(2)Cl(2), Et(2)O, acetone, and THF, respectively) are identified for 2(Peroxo), but they are not seen in 2(Oxo), revealing for the first time direct evidence for solvent coordination in the more open 2(Peroxo) structure.

Resonance raman investigation of equatorial ligand donor effects on the Cu(2)O(2)(2+) core in end-on and side-on mu-peroxo-dicopper(II) and bis-mu-oxo-dicopper(III) complexes.

The effect of endogenous donor strength on Cu(2)O(2) bonds was studied by electronically perturbing [[(R-TMPA)Cu(II)]](2)(O(2))](2+) and [[(R-MePY2)Cu](2)(O(2))](2+) (R = H, MeO, Me(2)N), which form the end-on mu-1,2 bound peroxide and an equilibrium mixture of side-on peroxo-dicopper(II) and bis-mu-oxo-dicopper(III) isomers, respectively. For [[(R-TMPA)Cu(II)](2)(O(2))](2+), nu(O-O) shifts from 827 to 822 to 812 cm(-1) and nu(Cu)(-)(O(sym)) shifts from 561 to 557 to 551 cm(-1), respectively, as R- varies from H to MeO to Me(2)N. Thus, increasing the N-donor strength to the copper decreases peroxide pi(sigma) donation to the copper, weakening the Cu-O and O-O bonds. A decrease in nu(Cu-O) of the bis-mu-oxo-dicopper(III) complex was also observed with increasing N-donor strength for the R-MePY2 ligand system. However, no change was observed for nu(O-O) of the side-on peroxo. This is attributed to a reduced charge donation from the peroxide pi(sigma) orbital with increased N-donor strength, which increases the negative charge on the peroxide and adversely affects the back-bonding from the Cu to the peroxide sigma orbital. However, an increase in the bis-mu-oxo-dicopper(III) isomer relative to side-on peroxo-dicopper(II) species is observed for R-MePY2 with R = H < MeO < Me(2)N. This effect is attributed to the thermodynamic stabilization of the bis-mu-oxo-dicopper(III) isomer relative to the side-on peroxo-dicopper(II) isomer by strong donor ligands. Thus, the side-on peroxo-dicopper(II)/bis-mu-oxo-dicopper(III) equilibrium can be controlled by electronic as well as steric effects.

Contrasting copper-dioxygen chemistry arising from alike tridentate alkyltriamine copper(I) complexes.

Copper(I)-dioxygen interactions are of great interest due to their role in biological O2-processing as well as their importance in industrial oxidation processes. We describe here the study of systems which lead to new insights concerning the factors which govern Cu(II)-mu-eta2:eta2 (side-on) peroxo versus Cu(III)-bis-mu-oxo species formation. Drastic differences in O2-reactivity of Cu(I) complexes which differ only by a single -CH3 versus -H substituent on the central amine of the tridentate ligands employed are observed. [Cu(MeAN)]B(C6F5)4 (1) (MeAN = N,N,N',N',N'-pentamethyl-dipropylenetriamine) reacts with O2 at -80 degrees C to form almost exclusively the side-on peroxo complex [{CuII(MeAN)}2(O2)]2+ (3) in CH2Cl2, tetrahydrofuran, acetone, and diethyl ether solvents, as characterized by UV-vis and resonance Raman spectroscopies. In sharp contrast, [Cu(AN)]B(C6F5)4 (2) (AN = 3, 3'-iminobis(N,N-dimethyl-propylamine) can support either Cu2O2 structures in a strongly solvent-dependent manner. Extreme behavior is observed in CH2Cl2 solvent, where 1 reacts with O2 giving 3, while 2 forms exclusively the bis-mu-oxo species [{CuIII(AN)}2(O)2]2+ (4Oxo). Stopped-flow kinetics measurements also reveal significant variations in the oxygenation reactions of 1 versus 2, including the observations that 4Oxo forms much faster than does 3; the former decomposes quickly, while the latter is quite stable at 193 K. The solvent-dependence of the bis-mu-oxo versus side-on peroxo preference observed for 2 is opposite to that reported for other known copper(I) complexes; the factors which may be responsible for the unusual behavior of 1/O2 versus 2/O2 (possibly N-H hydrogen bonding in the AN chemistry) are suggested. The factors which affect bis-mu-oxo versus side-on peroxo formation continue to be of interest.